Suppr超能文献

转化生长因子β直接调控原始小鼠造血细胞的增殖。

Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation.

作者信息

Keller J R, Mcniece I K, Sill K T, Ellingsworth L R, Quesenberry P J, Sing G K, Ruscetti F W

机构信息

Laboratory of Molecular Immunoregulation, Program Resources, Inc, National Cancer Institute, Frederick, MD 21701.

出版信息

Blood. 1990 Feb 1;75(3):596-602.

PMID:1967539
Abstract

We previously reported that transforming growth factor beta (TGF-beta) selectively inhibits colony-stimulating factor-driven hematopoietic progenitor cell growth. We report here that TGF-beta 1 can act directly on hematopoietic progenitors to inhibit the growth of the most primitive progenitors measurable in vitro. Highly enriched populations of hematopoietic progenitor cells were obtained by isolating lineage negative (Lin-), Thy-1-positive (Thy-1+) fresh bone marrow cells, or by isolating cells from interleukin-3 (IL-3) supplemented bone marrow cultures expressing Thy-1 antigen with the fluorescent activated cell sorter. TGF-beta 1 inhibited IL-3-induced Thy-1 expression on Thy-1-negative (Thy-1-) bone marrow cells in a dose-dependent manner with an ED50 of 5 to 10 pmol/L. In addition, TGF-beta 1 inhibited the formation of multipotent and mixed colonies by isolated Thy-1+ cells, while single lineage granulocyte and macrophage colonies were not affected. The growth of Thy-1+ Lin- cells incubated as single cells in Terasaki plates in medium supplemented with IL-3 were inhibited by TGF-beta, demonstrating a direct inhibitory effect. Hematopoietic stem cells, which have a high proliferative potential (HPP) when responding to combinations of growth factors in vitro, have been detected in the bone marrow of normal mice and mice surviving a single injection of 5-fluorouracil. TGF-beta 1 inhibited the growth of all subpopulations of HPP colony forming cells (CFC) in a dose-dependent manner with an ED50 of 5 to 10 pmol/L. Thus, TGF-beta directly inhibits the growth of the most immature hematopoietic cells measurable in vitro.

摘要

我们之前报道过,转化生长因子β(TGF-β)可选择性抑制集落刺激因子驱动的造血祖细胞生长。我们在此报告,TGF-β1可直接作用于造血祖细胞,以抑制体外可测量的最原始祖细胞的生长。通过分离谱系阴性(Lin-)、Thy-1阳性(Thy-1+)的新鲜骨髓细胞,或通过用荧光激活细胞分选仪从添加白细胞介素-3(IL-3)的骨髓培养物中分离表达Thy-1抗原的细胞,可获得高度富集的造血祖细胞群体。TGF-β1以剂量依赖方式抑制IL-3诱导的Thy-1阴性(Thy-1-)骨髓细胞上Thy-1的表达,半数有效剂量(ED50)为5至10 pmol/L。此外,TGF-β1抑制分离的Thy-1+细胞形成多能和混合集落,而单一谱系的粒细胞和巨噬细胞集落不受影响。在补充有IL-3的培养基中于Terasaki板中作为单细胞培养的Thy-1+ Lin-细胞的生长受到TGF-β的抑制,表明有直接抑制作用。造血干细胞在体外对生长因子组合作出反应时具有高增殖潜能(HPP),已在正常小鼠和单次注射5-氟尿嘧啶后存活的小鼠骨髓中检测到。TGF-β1以剂量依赖方式抑制HPP集落形成细胞(CFC)的所有亚群的生长,ED50为5至10 pmol/L。因此,TGF-β直接抑制体外可测量的最不成熟造血细胞的生长。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验